PT-141
Ships fully reconstituted · no mixing, no powder, no bacteriostatic waterOn-Demand Intimacy Enhancement
Enhances sexual desire and arousal by working through the nervous system, not vascular mechanics.
Choose your supply
Extra 10% off your first order · use code WELCOME10 at checkout (stacks with the supply discount above).
Frequently paired with
What it supports
- Enhances sexual desire and arousal
- Works for both men and women
- On-demand dosing flexibility
- Non-hormonal mechanism
- Addresses psychological aspects of intimacy
- Quick onset of action
- Supports overall sexual wellness
The details
- Administration
- Subcutaneous injection, on-demand
- Format
- 2mg/mL, 5mL vial
- Typical dosing
- 1.75mg subcutaneously 45 minutes before anticipated activity
- Best for
- Sexual desire, arousal, intimacy
- Pairs well with
- Selank, DSIP
- Mechanism
- PT-141 activates melanocortin receptors in the brain, particularly MC4R, which play a crucial role in sexual arousal and desire. It works centrally through the nervous system rather than affecting vascular function directly.
How it works
Signal
PT-141 is taken on demand — a single subcutaneous injection roughly 45 minutes before anticipated activity, at a provider-determined dose.
Cellular response
PT-141 activates melanocortin receptors in the brain, particularly MC4R, which play a central role in sexual arousal and desire. It works through the nervous system rather than affecting vascular function — a different pathway from PDE5 inhibitors like Viagra.
Outcome
Most people feel a shift in arousal within 30–60 minutes, lasting several hours; the first few uses are about finding your personal response window. Many report that simply having an effective option reduces performance anxiety on its own, and there is no tolerance buildup with on-demand use.
Sources & references
RECONNECT Phase 3 trial (women with HSDD)
Kingsberg SA et al. Obstet Gynecol. 2019;134(5):899–908.
View sourceErectile response in men, including sildenafil non-responders
Diamond LE et al. J Sex Med. 2006;3(4):628–638.
View sourceMelanocortin-receptor mechanism review
Pfaus JG et al. Pharmacol Ther. 2016;161:11–23.
View sourceBremelanotide phase 3 trials for hypoactive sexual desire disorder
Obstetrics & Gynecology, 2019
View sourceMelanocortin receptor agonists and sexual response
Pharmacology & Therapeutics, 2010
View sourcePT-141 safety and cardiovascular profile
Journal of Sexual Medicine, 2018
View sourceBremelanotide post-marketing experience
Drug Safety, 2021
View source
Common questions
Important safety information
PT-141 is available by prescription only and is dispensed after a licensed provider reviews your medical screening and determines it is appropriate for you. Compounded medications are prepared by a licensed U.S. pharmacy and are not FDA-approved products. Tell your provider about your full medical history and any medications you take.
- • May cause temporary flushing or nausea
- • Possible mild blood pressure changes
- • Should not be used during pregnancy or breastfeeding
- • Requires licensed provider evaluation and prescription